What Is the ACR-Guided Imaging for Surveillance of High-Risk Melanoma?
ACR-guided imaging workflow for Adult. Cutaneous or muco-cutaneous melanoma. Positive clinical or surgical regional lymph nodes or metastatic disease at in
ACR-guided imaging workflow for Adult. Cutaneous or muco-cutaneous melanoma. Positive clinical or surgical regional lymph nodes or metastatic disease at in
ACR-guided imaging workflow for Adult. Cutaneous or muco-cutaneous melanoma. Negative clinical or surgical regional lymph nodes or metastatic disease at in
ACR-guided imaging workflow for Adult. Newly diagnosed cutaneous or muco-cutaneous melanoma. Microscopic satellite in primary lesion biopsy specimen, or po
ACR-guided imaging workflow for Adult. Newly diagnosed cutaneous or muco-cutaneous melanoma. No signs or symptoms of regional or metastatic disease. No pat
ACR-guided imaging workflow for Adult. Acute or chronic symmetric weakness. Suspect demyelinating disease of the peripheral nervous system. Initial imaging
ACR-guided imaging workflow for Adult. Known demyelinating disease. New or progressive neurologic deficits. Initial imaging. (Demyelinating Diseases): reco
ACR-guided imaging workflow for Adult. Known demyelinating disease. Stable neurologic examination. Surveillance imaging. (Demyelinating Diseases): recommen
ACR-guided imaging workflow for Adult. Acute or subacute sensorimotor symptoms below a spinal cord level. Suspect transverse myelitis. Initial imaging. (De
ACR-guided imaging workflow for Adult. Acute or subacute sensorimotor or brainstem symptoms. Suspect demyelinating disease of the central nervous system. I
ACR-guided imaging workflow for Adult of any age. Female or transfeminine. Suspected breast implant-associated malignancy. Breast implant of any type. Init